BioWorld MedTech

Aug. 5, 2011

Medtronic recruits Yale to review Infuse clinical trials

Medtronic (Minneapolis) reported that it is funding two independent reviews of studies of its Infuse bone graft in the wake of criticism of the clinical trials it conducted to support the device. (Medical Device Daily) Read More

Need to check your glucose? There may be an app for that

International report: Misonix enters 3-year product distribution agreement in Taiwan

Deals roundup: Emdeon enters into $3 billion merger with Blackstone Capital

Financings roundup: NeoChord raises $5M, seeks $11M for mitral regurgitation treatment

MDD's food for med-tech thought

Agreements/contracts: LABSCO to distribute systems and test kits for Diamedix

HIT roundup: ActiveCare device monitors vital signs for seniors

Product Briefs

Med-Tech Notes

People in the News

MDD's Diagnostic Extra

Today's news in brief

BioWorld

BioWorld briefs for Jan 23, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 23, 2026.

Illustration of magnifying glass inspecting brain

Neurotrimin unveiled as marker in intellectual disability

BioWorld Science

Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...

DNA mutations or genetic disorder concept art

Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease

BioWorld Science

Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...

Illustration of human body surrounded by DNA, cell and drug icons

Cell/gene therapy sector now sustainable; China competition mounting

BioWorld

There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...